Peptide record

TPDB64370

HALA1 Cell-penetrating Peptides standard
30 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB64370
HALA1
Cell-penetrating Peptides
Delivery and barrier-penetrating peptides
CPPsite3.0
standard
No
A 30-aa standard natural cell-penetrating peptides peptide sequence curated from CPPsite3.0, with an available 3D structural model.
Sequence
WEAHLAHALARALARHLARALARALRACEA
Physicochemical Analysis
C144H238N52O35S1
NDQGIKMFPSTYV
A
3289.86
11.80
8
2
19
+3
3.48
0.230
118.00
Mammalian: 2.8 hour Yeast: 3 min E.coli: 2 min
5500
167.18
1
Residue Composition
number
12
A
5
R
0
N
0
D
1
C
2
E
0
Q
0
G
3
H
0
I
6
L
0
K
0
M
0
F
0
P
0
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 12 R: 5 N: 0 D: 0 C: 1 E: 2 Q: 0 G: 0 H: 3 I: 0 L: 6 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
30
C144H238N52O35S1
3289.86
11.80
+3
3.48
0.230
Free
L
Linear
Free
N[C@@H](CC1=C(C(=NC1)C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O
Evidence Records 1 records
Evidence 1 Activity

Activity

Cell-penetrating Peptides

Target

HeLa, A549, And HEK-293T Cell Line

Source & Reference

CPPsite3.0
CPPsite3

Other

Source Activity Label Source Definition
Cell-penetrating Peptides
CPPsite3.0 experimentally validated cell-penetrating peptide annotation.
Natural residues Linear L
Synthetic
5'Cy3-modified non-target siRNA and pCMV-Enhanced Green Fluorescent Protein (EGFP) plasmid DNA
pDNA transfection of HALA1 group was above 45% in HeLa cells and lower than RALA in A549 cells.
More than one endocytosis pathways
In vitro
CCCSCCHHHHHHCCHHHHHHHHHHHCC
Additional Detail Fields 1 fields
CCCSCCHHHHHHCCHHHHHHHHHHHCC